![Aurelio Fernandez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aurelio Fernandez
Direttore/Membro del Consiglio presso Aquyre Biosciences, Inc.
Posizioni attive di Aurelio Fernandez
Società | Posizione | Inizio | Fine |
---|---|---|---|
Aquyre Biosciences, Inc.
![]() Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Aurelio Fernandez
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Aquyre Biosciences, Inc.
![]() Aquyre Biosciences, Inc. Medical/Nursing ServicesHealth Services Aquyre Biosciences, Inc. is a biotech company that created Celtivity™, a rapid digital specimen adequacy assessment tool that can identify the presence of cancer cells and immune cells in a biopsy in just two minutes. The company is based in Weston, MA and was founded by Bertrand Le Conte de Poly, Claude Boccara. The assessment is presented as a cellular heatmap, making analysis and detection of cancer, granuloma, and immune cells such as lymphocytes relatively easier than traditional cancer diagnostic methods. Floyd Samuel Eberts has been the CEO of the company since 2023. | Health Services |
- Borsa valori
- Insiders
- Aurelio Fernandez
- Esperienza